Related Experiment Video
Updated: Jun 12, 2026

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy
1Laboratory of Molecular Translational Medicine, West China Second University Hospital, Sichuan University, Chengdu 610041, PR China.
Background:
Common single nucleotide polymorphisms (SNPs) in pre-microRNAs may change their property through altering microRNAs (miRNAs) expression and/or maturation, resulting diverse functional consequences. We conducted a pilot study to test whether SNPs in pre-microRNAs were associated with dilated cardiomyopathy (DCM).
Methods:
Genotypes of 3 SNPs in pre-miRNAs (has-mir-196a2 rs11614913 C/T, hsa-mir-499 rs3746444 A/G, hsa-mir-146a rs2910164 C/G) in 221 DCM patients and 321 control subjects were determined with the use of PCR-restriction fragment length polymorphism (RFLP) assay.
Results:
Significantly increased DCM risks were found to be associated with variant allele of has-mir-196a2 rs11614913 C/T (T allele) and hsa-mir-499 rs3746444 A/G (G allele) (P<0.0001, OR=1.730, 95% CI=1.345-2.227, and P<0.0001, OR=1.794, 95% CI=1.350-2.385, respectively). We found that increased DCM risk was statistically significantly associated with these 2 SNPs in a dominant model (P=0.0001 and P<0.0001 for rs11614913 and rs3746444, respectively). No association between DCM risk and hsa-mir-146a rs2910164 C/G was observed (P=0.451, OR=1.102, 95% CI=0.856-1.418).
Conclusions:
Both the has-mir-196a2 rs11614913 C/T and hsa-mir-499 rs3746444 A/G, but not hsa-mir-146a rs2910164 C/G, are associated with a significantly increased risk of DCM, indicating that common genetic polymorphisms in pre-microRNAs are associated with DCM.
Insights
Common single nucleotide polymorphisms in pre-microRNAs are linked to increased risk of dilated cardiomyopathy (DCM). Specifically, variants in has-mir-196a2 and hsa-mir-499 are associated with higher DCM risk.
Area of Science:
- Genetics
- Molecular Biology
- Cardiology
Background:
- Single nucleotide polymorphisms (SNPs) in pre-microRNAs can alter microRNA (miRNA) expression and function.
- These alterations may lead to various functional consequences, potentially impacting disease development.
Purpose of the Study:
- To investigate the association between common SNPs in pre-microRNAs and the risk of developing dilated cardiomyopathy (DCM).
- This pilot study aimed to identify specific pre-miRNA SNPs linked to DCM susceptibility.
Main Methods:
- Genotyping of three pre-miRNA SNPs (has-mir-196a2 rs11614913 C/T, hsa-mir-499 rs3746444 A/G, hsa-mir-146a rs2910164 C/G) was performed.
- The study included 221 DCM patients and 321 healthy control subjects, with genotyping conducted using PCR-restriction fragment length polymorphism (RFLP) assay.
Main Results:
- The variant alleles of has-mir-196a2 rs11614913 (T allele) and hsa-mir-499 rs3746444 (G allele) were significantly associated with increased DCM risk (P<0.0001 for both).
- A dominant model showed a statistically significant association between these two SNPs and increased DCM risk.
- No significant association was observed between DCM risk and the hsa-mir-146a rs2910164 C/G polymorphism (P=0.451).
Conclusions:
- The study concludes that common genetic polymorphisms in pre-microRNAs, specifically has-mir-196a2 rs11614913 C/T and hsa-mir-499 rs3746444 A/G, are associated with a significantly increased risk of dilated cardiomyopathy.
- The hsa-mir-146a rs2910164 C/G polymorphism was not found to be associated with DCM risk in this cohort.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
MicroRNAs
MicroRNAs
Cardiomyopathy II: Dilated Cardiomyopathy
Pharmacogenomics: Identification of New Drug Targets
Cardiomyopathy I: Introduction and Classification
